#TargetedTherapy
LightNews LightNews
eanoassociation.bsky.social
📣 Just Released: The #EANO Guideline on molecular testing of #meningiomas for targeted therapy selection!
Evidence-based guidance for patient care & clinical trials, and show of areas for which additional research is warranted. doi.org/10.1093/neuo... #TargetedTherapy #ICOM @oncoalert.bsky.social
November 23, 2024 at 4:09 PM
coherentcmi.bsky.social
Oncology Precision Medicine Market Size, Trends, and Growth Outlook 2026-2033

www.coherentcmi.com/industry-rep...

#CancerTreatment #TargetedTherapy #CancerCare #LiquidBiopsy #MedicalResearch #HealthcareTechnology #MedTech #MarketResearch #GlobalMarket
September 22, 2026 at 6:30 AM
cancergrace.bsky.social
Dr. @JuliaRotow presenting now: EGFR Combination Therapies.

#LungCancer #EGFR #TargetedTherapy
December 14, 2024 at 5:10 PM
oncodaily.bsky.social
Encorafenib, cetuximab, and chemotherapy in BRAF-mutant colorectal cancer
@arndtvogel.bsky.social

oncodaily.com/blog/encoraf...

#BRAFmutant #CRC #BREAKWATERtrial #Cancer #Cetuximab #Chemotherapy #ClinicalTrials #CRC #ESMO #OncoDaily #Health #Oncology #PrecisionOncology #Medicine #TargetedTherapy
Encorafenib, cetuximab, and chemotherapy in BRAF-mutant colorectal cancer - OncoDaily
Encorafenib, cetuximab, and chemotherapy in BRAF-mutant colorectal cancer / Arndt Vogel, BRAF mutant CRC, BRAF mutation, BREAKWATER trial, cancer, Cancer
oncodaily.com
February 2, 2025 at 4:28 PM
latinamd.bsky.social
So many abstracts so little time⌚!
Here are #ASCO25 Top Lung Cancer Abstract Presentations to watch for -Part 1
Not a lot of new drugs but important updates on #perioperative and #targetedtherapy trials. Full abstracts available 5/22.
#lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
May 15, 2025 at 10:30 AM
seldon-dengyue.bsky.social
📢 Breaking News in Oncology!
The NMPA has conditionally approved #Zeprumetostat Tablets (#Airuijing) by Jiangsu Hengrui Pharmaceuticals.

#JiangsuHengrui #InnovationDrug #PeripheralTCellLymphoma #RrPTCL #RelapsedCancer #RefractoryCancer #EZH2Inhibitor #TargetedTherapy #NMPA
#HongKongDengYueMedicine
November 3, 2025 at 7:04 AM
oncodaily.bsky.social
Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

oncodaily.com/stories/cele...

#100InfluentialCelebritiesInOncology #Advocacy #Medicine #KidneyCancer #Cancer #Headlines #Health #Oncology #KidneyCancerAdvocacy #KidneyCancerAwareness #OncoDaily #TargetedTherapy
Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle - OncoDaily
Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle / 100 Influential Celebrities in Oncology, advocacy kidney cancer,
oncodaily.com
December 15, 2024 at 5:18 PM
oncodaily.bsky.social
Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Craniopharyngioma #BrainTumor #PituitaryTumor #ProtonTherapy #TargetedTherapy
Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care - OncoDaily
Craniopharyngioma is a rare brain tumor near the pituitary. Learn about its symptoms, diagnosis, treatment, prognosis, and 2025 targeted therapy advances.
oncodaily.com
May 15, 2025 at 10:40 PM
myesmo.bsky.social
📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance.
#LungCancer #mNSCLC #ESMOGuidelines

🔗 buff.ly/DSLyGib
June 24, 2025 at 8:02 AM
peerview.bsky.social
🚨 Don’t miss our symposium tomorrow at #SNO2024! Join Drs. Ahluwalia & Wen for expert insights on #IDH-mutated #gliomas, #biomarker testing, & #targetedtherapy.
💻 PeerView.com/2024Glioma
🕔 5:15 PM CST (Reg & Dinner 🍽️) | 5:30 PM CST (Symposium)
📍 Room 332, Houston Convention Center & Virtual
MDADI
MDADI
PeerView.com
November 20, 2024 at 11:52 PM
oncodaily.bsky.social
Taletrectinib (Ibtrozi): What Patients Should Know in 2025?

oncodaily.com/drugs/taletr...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Taletrectinib #Ibtrozi #NSCLC #LungCancer #TargetedTherapy
Taletrectinib (Ibtrozi): What Patients Should Know About in 2025? - OncoDaily
Learn more about Taletrectinib (Ibtrozi), its uses in cancer, side effects and their management, dosage, and what patients should expect.
oncodaily.com
July 11, 2025 at 8:46 PM
oncodaily.bsky.social
Meet the AIEOP’s 2024-2027 Board Of Directors: President, Angela Mastronuzzi

oncodaily.com/blog/aieop-2...

#AIEOP #Cancer #CellTherapy #ChildNeurology #ClinicalTrials #ERNPaedCanNetworks #GeneTherapy #ITCCConsortium #MolecularScience #OncoDaily #Oncology #PediatricCancer #TargetedTherapy #Tumors
Meet the AIEOP's 2024-2027 Board Of Directors: President, Angela Mastronuzzi - OncoDaily
Meet the AIEOP's 2024-2027 Board Of Directors: President, Angela Mastronuzzi / AIEOP, Bambino Gesù Children's Hospital, cancer, Catholic University of the
oncodaily.com
December 28, 2024 at 4:30 PM
oncodaily.bsky.social
Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Pheochromocytoma #AdrenalGland #Catecholamines #Hypertension #Immunotherapy #TargetedTherapy
Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management - OncoDaily
Paraganglioma and pheochromocytoma are rare neuroendocrine tumors. Learn the key differences in origin, symptoms, and diagnosis.
oncodaily.com
May 20, 2025 at 9:32 PM
arxivlens.bsky.social
Assessing the Suitability of Deubiquitylases As Substrates For Targeted Protein Degradation
Burke, J., Kodadek, T. et al.
Paper
Details
#ProteinDegradation #TargetedTherapy #DeubiquitinasesResearch
June 15, 2025 at 11:36 AM
miguel-miranda.bsky.social
3/ To overcome this resistance, we found that combining MEK inhibitors with PDGFR/RAF-dimer inhibitors can improve treatment response.

This highlights a promising new strategy for tackling MPNST!

#TargetedTherapy #Research
November 25, 2024 at 10:42 AM
myesmo.bsky.social
#ESMOAsia25: Studies in cancer of unknown primary (#CUP) highlight the need to perform routine comprehensive #GenomicProfiling and then provide access to the appropriate #TargetedTherapy. Find out more in the #ESMODailyReporter ➡️https://ow.ly/sK6H50XF5t7

December 7, 2025 at 11:05 AM
lungenforschung.bsky.social
📊 Erste Real-World-Daten zu Zongertinib bei HER2+ NSCLC: Klin. & radiolog. Benefit bei allen Patient:innen inkl. kompletter Remission von Hirnmetastasen, Gute Verträglichkeit. Mehr erfahren? s. Kommentar.
#lcsm #oncology #her2 #zongertinib #targetedtherapy @oliverillini.bsky.social
February 7, 2025 at 2:47 PM
onco404.bsky.social
A real-world study from France highlights zanidatamab as a promising therapy for HER2-positive advanced biliary tract cancers ( #BTC ).

@eortc.org #EJC

#Onco404 #Cancer #Kanser #PrecisionMedicine #KişiyeÖzelTedavi #MedSky #OncSky #BiliaryTractCancer #HER2 #TargetedTherapy #MonoclonalAntibody
April 27, 2025 at 9:02 AM
world-j-pediatr.bsky.social
New hope for kids with brain tumors: Targeted therapies like tovorafenib show 51% response rate in pediatric gliomas, with RNA sequencing improving diagnosis to 97% accuracy.

#Meded #SoMe4PedSurg #Glioma #TargetedTherapy #SignalingPathway #Pediatrics #PublicHealth

link.springer.com/article/10.1...
April 15, 2025 at 4:31 AM
oncodaily.bsky.social
Join us for the AACR Special Conference on Translating Radiation and Targeted Therapy Combinations - Albert Koong
@ackoongmdphd.bsky.social
@theaacr.bsky.social

oncodaily.com/blog/albert-...

#AACR #Cancer #OncoDaily #Oncology #TargetedTherapy #Medicine #Health
Albert Koong: Join us for the AACR Special Conference on Translating Radiation and Targeted Therapy Combinations - OncoDaily
Albert Koong: Join us for the AACR Special Conference on Translating Radiation and Targeted Therapy Combinations / AACR, Albert Koong, cancer, Michael
oncodaily.com
January 3, 2025 at 6:12 PM
cjkhd.bsky.social
A Narrative Review of #C3Glomerulopathy: From Pathogenesis to Targeted Therapy #narrativereview #targetedtherapy #kidneyresearch
@csnscn.bsky.social

doi.org/10.1177/2054...
The complement AP is overactive in C3G. See article for further information
May 25, 2026 at 11:29 AM
cp-iscience.bsky.social
Can targeting #SUMOylation open new doors in #OvarianCancer treatment? 🔍🧬

New #iScience study screened 30 patient-derived models — finding #MYC sensitivity & #ABCB1 resistance. A step toward #PersonalisedMedicine 💡

🧾 www.sciencedirect.com/science/arti...

#CancerResearch #TargetedTherapy #Drug
May 19, 2025 at 12:39 PM
oncodaily.bsky.social
A True Game Changer in Targeted Therapy for Lung Cancer - Alfredo Addeo
@alfdoc2.bsky.social
@jillfeldman4.bsky.social

oncodaily.com/science/targ...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TargetedTherapy #LungCancer #TKIs
Alfredo Addeo: A True Game Changer in Targeted Therapy for Lung Cancer - OncoDaily
Alfredo Addeo: A True Game Changer in Targeted Therapy for Lung Cancer / Alfredo Addeo, CA: A Cancer Journal for Clinicians, cancer, Claudio De Vito, Giuseppe
oncodaily.com
July 18, 2025 at 11:38 PM
myesmo.bsky.social
Next‑generation #ADCs are changing oncology practice.

Join the #ESMOOnAir webinar on trial design, novel targets & toxicity management.
Register now 👉 https://ow.ly/4a5k50Z322z

#ESMOWebinars #TargetedTherapy #CancerResearch
May 26, 2026 at 8:00 AM
drjkyl.bsky.social
Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#medicaloncology #combinationtherapy #targetedtherapy #oncosky #medsky #openaccess
August 8, 2025 at 4:45 PM